The results of this study showed that SLAMF6 expression was associated with elevated anti-cancer immune activity and better prognosis both in the ‘cold’ tumor (breast cancer) and the ‘hot’ tumor (melanoma). The gene discussed is SLAMF6; the disease is breast carcinoma.